CXCR5 Recombinant antibody

CXCR5 Recombinant Antibody for WB, ELISA
Cat No. 84639-2-RR

产品说明书

CloneNo. 241777A10

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

WB, ELISA

CXCR 5, CXC R5, CD185, Burkitt lymphoma receptor 1, BLR1

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inDaudi cells, Raji cells, Ramos cells, Jurkat cells, K-562 cells

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:2000-1:10000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

84639-2-RR targets CXCR5 in WB, ELISA applications and shows reactivity with human samples.

经测试应用 WB, ELISA Application Description
经测试反应性 human
免疫原 Peptide 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 chemokine (C-X-C motif) receptor 5
别名 CXCR 5, CXC R5, CD185, Burkitt lymphoma receptor 1, BLR1
计算分子量 372 aa, 42 kDa
观测分子量33 kDa
GenBank蛋白编号BC110352
基因名称 CXCR5
Gene ID (NCBI) 643
RRIDAB_3672098
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purfication
UNIPROT IDP32302
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Initially discovered in 1992 as Burkitt's lymphoma receptor 1, CXCR5 (chemokine receptor 5, also known as CD185) is a seven-transmembrane G protein-coupled receptor (GPCR) protein (PMID: 32994482). CXCR5 is essential for naïve B-cell migration to and maturation in the lymph nodes and spleen, as well as for cluster of differentiation 4 T-cell (TFH and TCM) homing and interaction with B cells (PMID: 21471443). Moreover, CXCR5 is involved in the regulation of neural stem cells (NSC) and neuronal regeneration in the mouse brain, neuronal differentiation, neurogenesis, gliogenesis, and synaptogenesis (PMID: 37460877).

实验方案

Product Specific Protocols
WB protocol for CXCR5 antibody 84639-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...